Predict your next investment

HEALTHCARE | Biotechnology
neubasetherapeutics.com

See what CB Insights has to offer

Founded Year

2009

Stage

IPO | IPO

Date of IPO

4/27/2021

Market Cap

0.10B

Stock Price

2.84

About NeuBase

NeuBase (NASDAQ: NBSE) develops a modular antisense technology platform with the capability to address rare genetic diseases caused by mutant proteins with a single, cohesive approach. NeuBase's platform improves upon gene silencing therapies by combining the advantages of synthetic approaches with the precision of antisense technologies.

NeuBase Headquarter Location

2730 Sidney St

Pittsburgh, Pennsylvania, 15203,

United States

Latest NeuBase News

NeuBase to Present at the Jefferies London Healthcare Conference

Nov 3, 2021

About NeuBase Therapeutics NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease. NeuBase’s targeted PATrOL™ therapies are centered around its proprietary drug scaffold to address genetic diseases at the DNA or RNA level by combining the highly targeted approach of traditional genetic therapies with the broad organ distribution capabilities of small molecules. With an initial focus on silencing disease-causing mutations in debilitating neuromuscular, neurological and oncologic disorders, NeuBase is committed to redefining medicine for the millions of patients with both common and rare conditions. To learn more, visit www.neubasetherapeutics.com . Investor Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

NeuBase Patents

NeuBase has filed 3 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • DNA
  • Genetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/15/2021

Molecular biology, Genetics, RNA, Biotechnology, DNA

Application

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/15/2021

00/00/0000

00/00/0000

Grant Date

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Genetics, RNA, Biotechnology, DNA

Subscribe to see more

Subscribe to see more

Status

Application

Subscribe to see more

Subscribe to see more

NeuBase Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NeuBase Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.